Heptares TherapeuticsCompany Details

Get alertedif Heptares Therapeutics gets funded!
Country:
City:
United Kingdom
Welwyn Garden City
Industry:Biotechnology
Detailed industries:biotechnology
Company description

eptares creates new medicines targeting clinically important, yet historically challenging, GPCRs (G protein-coupled receptors), a superfamily of drug receptors linked to a wide range of human diseases. Leveraging our advanced structure-based drug design technology platform, we have built an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, migraine and diabetes. Our pharmaceutical partners include Shire, AstraZeneca, MedImmune, Morphosys, Takeda and Cubist, and ...we are backed by MVM Life Science Partners, Clarus Ventures, Novartis Venture Fund, Stanley Family Foundation and Takeda Ventures MoreLess

 

Funding history

Create alert
Want to know when Heptares Therapeutics gets funded?
Key people
Dr. Anja KönigBoard Positions
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!